Atea Pharmaceuticals Inc
(NAS:AVIR)
$
3.36
0.01 (0.3%)
Market Cap: 283.66 Mil
Enterprise Value: -218.22 Mil
PE Ratio: 0
PB Ratio: 0.60
GF Score: 41/100 Atea Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 13, 2023 / 02:10PM GMT
Release Date Price:
$3.3
(+0.30%)
Maxwell Nathan Skor
Morgan Stanley, Research Division - Former Research Associate
Hello, everyone. I'm Maxwell Skor, Biotech Analysts with Morgan Stanley. And before we get started, I need to read an important disclosure. Please note that all important disclosures including personnel holdings disclosures and Morgan Stanley disclosures appear in the Morgan Stanley public website at www.morganstanley.com/researchdisclosures.
And with that, I would like to welcome the Atea team, specifically Andrea Corcoran, CFO; Janet Hammond, CDO; Arantxa Horga, CMO; and John Vavricka, CCO.
Questions & Answers
Maxwell Nathan Skor;Janet M. J. Hammond
Morgan Stanley, Research Division - Former Research Associate;Atea
And with that, I think it would be best if we off the top, I guess, have a broader discussion on COVID overall, and then we can kind of dive into the pipeline. So can you provide your view on the current state of the pandemic?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot